Loading
Marvel Biosciences Corp. Formerly Alphanco Venture Corp. Stock: price and insider trades · Canada
CA·Mcap CA$8.5M
Marvel Biosciences Corp. Formerly Alphanco Venture Corp.: what insiders have been doing
This page follows insider dealings at Marvel Biosciences Corp. Formerly Alphanco Venture Corp. as filed with SEDI. The last twelve months, up to 18 October 2026, brought 6 filings signed by 5 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €3,082. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. At €3,082, the purchase published on 14 August 2026 by Matheson, Joseph Roderick is the largest of the period (0.053% of market cap). Among those who bought: 1 senior executive.
For context, the typical company on the same exchange (median of 2,120 companies) published 12 filings over the same period, against 6 filings here. The full history, which starts in 2026, counts 1 purchase against no sales.
The last insider purchase was made public on 14 August 2026, 64 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€3,082
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJoseph Roderick Matheson1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended July 2025 · cache
CA$0.12
Analyst consensus
Income statement
Gross profit-CA$547.4k
EBITDA-CA$1.9M
Net income-CA$2.2M0.0% margin
Valuation
Beta0.49
Balance sheet & cash
Market capCA$8.5M
Total debtCA$2.3M
Free Cash Flow-CA$1.2M
Profitability & ownership
ROA-172.1%
% insiders22.3%
% institutions0.0%
Last declaration on 1 September 2026
Declarations6 total
16,667 sharesDeferred Share UnitsTSXSEDI:4770893
16,667 shares@ CA$0.150.026% mcap100.0% of flowDeferred Share UnitsTSXSEDI:4770888
16,667 sharesDeferred Share UnitsTSXSEDI:4770734
250,000 shares@ CA$0.1650.44% mcap100.0% of flowCommon SharesTSXSEDI:4766671
600,000 shares@ CA$0.1651.05% mcap95.2% of flowCommon SharesTSXSEDI:4766654
30,000 shares@ CA$0.1650.053% mcap4.8% of flowCommon SharesTSXSEDI:4764733
Canonical exit: 12 Nov 2026 (T+90)
6 of 6 declarations
About Marvel Biosciences Corp. Formerly Alphanco Venture Corp.
Marvel Biosciences Corp., formerly known as Alphanco Venture Corp., is a Toronto Stock Exchange-listed company focused on developing biopharmaceutical solutions.
